US Patent

US11091459 — Niraparib compositions

Composition of Matter · Assigned to Merck Sharp and Dohme LLC · Expires 2038-03-27 · 12y remaining

Vulnerability score 12/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects compositions of the compound niraparib, specifically certain solid forms of niraparib.

USPTO Abstract

The present invention relates to compositions comprising the compound niraparib, in particular certain solid forms of niraparib.

Drugs covered by this patent

Patent Metadata

Patent number: US11091459
Jurisdiction: US
Classification: Composition of Matter
Expires: 2038-03-27
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Merck Sharp and Dohme LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.